Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Market Value Is The Sterile Compounding Pharmacies Industry Expected To Reach By 2029, Starting From 2025 Levels?
The sterile compounding pharmacies market size has experienced strong growth over recent years. It is forecast to expand from $5.34 billion in 2024 to $5.62 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.2%. This past growth can be ascribed to patient safety concerns, a shift towards personalized medicine, home infusion therapies, clinical trials and investigational drugs, and support for rare diseases.
The sterile compounding pharmacies market is projected to experience substantial expansion in the coming years. By 2029, its valuation is set to reach $7.26 billion, demonstrating a compound annual growth rate (CAGR) of 6.6%. This growth during the forecast period is primarily driven by factors such as the increasing prevalence of chronic diseases, an expanding aging population and evolving healthcare demands, issues like drug shortages and supply chain interruptions, innovations in precision medicine, and a heightened emphasis on patient-centric care. Key trends shaping the forecast period encompass the incorporation of automation and robotics, adherence to strict regulatory compliance, the development of personalized medicine and specialized compounds, a move towards outsourced compounding services, and continuous technological progress in aseptic techniques.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12073&type=smp
Which Drivers Are Shaping The Sterile Compounding Pharmacies Industry’s Market Share?
The sterile compounding pharmacies market is projected to expand due to the rising demand for personalized medicine. This medical approach involves preventing, diagnosing, or treating illnesses through the utilization of genetic or protein data specific to an individual. Sterile compounding pharmacies are crucial in delivering personalized medications within a sterile setting, tailoring treatments to individual patient needs and thereby preventing adverse reactions to specific dosages or pharmaceutical ingredients. This approach enhances therapeutic outcomes and boosts patient satisfaction and compliance with treatment regimens. For example, data from 2022, reported by the US-based Personalized Medicine Coalition, which specializes in personalized medicine services, indicates a significant surge in personalized medicine approvals, now representing at least a quarter of all new medication approvals, with 12 new personalized medicines sanctioned in 2022. Consequently, the growing need for personalized medicine serves as a key driver for the sterile compounding pharmacies market.
What Are The Leading Segments Analyzed In The Sterile Compounding Pharmacies Market?
The sterile compounding pharmaciesmarket covered in this report is segmented –
1) By Product: Injectables; Nasal; Ocular; Otic
2) By Therapeutic Area: Hormone Replacement Therapy; Pain Management; Dermatology; Oncology; Hematology; Dental; Other Therapeutic Areas
3) By Route Of Administrations: Intravenous; Intramuscular; Subcutaneous
4) By End-Users: Adults; Pediatrics; Geriatrics; Veterinary
Subsegments:
1) By Injectables: Sterile Solutions; Sterile Suspensions; Sterile Powders For Reconstitution
2) By Nasal: Nasal Sprays; Nasal Solutions; Nasal Gels
3) By Ocular: Ophthalmic Solutions; Ophthalmic Suspensions; Ocular Inserts
4) By Otic: Otic Solutions; Otic Suspensions; Otic Gels
Which Ongoing Trends Are Expected To Shape The Sterile Compounding Pharmacies Market Outlook?
Robotic automation is emerging as a significant and increasingly adopted trend within the sterile compounding pharmacies market. Leading entities within this market segment are prioritizing robotic automation to enhance their competitive standing. An illustrative example is Omnicell Inc., a US-based healthcare technology firm, which unveiled its IVX Station in March 2023. This technology represents a robotic compounding solution aimed at automating the creation of sterile compounding preparations safely and efficiently. The IVX Station is characterized by an automated compounding procedure conducted in an ISO Class 5 setting, complemented by continuous monitoring of temperature, humidity, and particles. Its design additionally incorporates safety elements, including advanced vision systems, gravimetric verification, auto-labeling, and the automatic application of tamper-evident syringe caps. Moreover, this innovative technology provides scalability through a cloud-based formulation library, which undergoes constant updates to ensure manufacturers have access to the latest approved formulations.
Which Major Industry Participants Are Leading The Sterile Compounding Pharmacies Market Growth?
Major companies operating in the sterile compounding pharmacies market include B. Braun SE, PharMerica Corporation, Fagron Group BV, QuVa Pharma Inc., NewCo Pharma GmbH, Medisca, PharMEDium Healthcare Holdings Inc., Central Admixture Pharmacy Services (CAPS), SandsRx LLC, LeeSar Inc., Avella Specialty Pharmacy, Stokes Pharmacy Inc., Imprimis Pharmaceuticals Inc., Wells Pharmacy Network LLC, McGuff Compounding Pharmacy Services Inc., Potter’s House Apothecary Inc., Pharos Innovations LLC, Triangle Compounding Pharmacy Inc., Valor Compounding Pharmacy Inc., Pace Pharmacy, PenCol Specialty Pharmacy LLC, Pavilion Compounding Pharmacy LLC, Olympia Pharmacy, MedisourceRx, Stat RX Pharmacy, Rx3 Compounding Pharmacy, Atlas Pharmaceuticals Co. Ltd., ReNue Rx, Premier Pharmacy Labs Inc., Absolute Pharmacy Inc.
Download The Full Report For Exclusive Market Findings:
What Are The Key Regional Factors Influencing The Sterile Compounding Pharmacies Market Growth?
North America was the dominant region in the sterile compounding pharmacies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sterile compounding pharmacies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Sterile Compounding Pharmacies Market Report:
https://www.thebusinessresearchcompany.com/customise?id=12073&type=smp
Browse Through More Reports Similar to the Global Sterile Compounding Pharmacies Market 2025, By The Business Research Company
Single Family Modular And Prefabricated Housing Construction Global Market Report 2025
Cement And Concrete Products Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cement-and-concrete-products-global-market-report
Mineral Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/mineral-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model